Ambey Laboratories Ltd

Ambey Laborator. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ambey Laboratories Ltd

₹ 40.0 0.00%
12 Dec - close price
ambeylab.com NSE - SME: AMBEY
About

Incorporated in 1985, Ambey Laboratories manufactures agrochemical products for crop protection.[1]

Key Points

Agro Chemical Products[1]
2,4-D Amine Salt (480 gm. Liter SL)
2,4-D Amine Salt (625 gm. Liter SL)
2,4-D Amine Salt (720 gm. Liter SL)
2,4-D Amine Salt (806 gm. Liter SL)
2,4-D Amine Salt (840 gm. Liter SL)
2,4-D Amine Salt (866 gm. Liter SL)
2,4-D Acid Tech (98% min)
2,4-D Ethyl Ester Tech (95% min)
2,4-D 2-Ethylhexyl Ester Tech (96% min)
2,4-D Sodium Salt (95% min)
Hexaconazole (5% min)

Website NSE - SM
  • Market Cap ₹ 99.8 Cr.
  • Current Price ₹ 40.0
  • High / Low ₹ 71.8 / 31.0
  • Stock P/E 22.5
  • Book Value ₹ 36.7
  • Dividend Yield 0.00 %
  • ROCE 9.97 %
  • ROE 8.75 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 1.09 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 60.5 to 112 days.
  • Working capital days have increased from 64.4 days to 126 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2024 Sep 2024 Mar 2025 Sep 2025
60 68 64 68
56 62 60 62
Operating Profit 4 6 4 6
OPM % 7% 9% 6% 9%
1 1 1 0
Interest 1 2 1 1
Depreciation 1 1 2 2
Profit before tax 3 4 2 3
Tax % 33% 18% 25% 13%
2 3 2 3
EPS in Rs 0.94 1.19 0.73 1.05
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
82 85 105 120 131 132
72 74 97 111 122 122
Operating Profit 10 10 8 9 10 10
OPM % 12% 12% 7% 8% 7% 7%
1 1 3 1 2 1
Interest 4 3 2 2 3 2
Depreciation 3 3 3 2 3 4
Profit before tax 3 5 6 6 6 5
Tax % -235% 26% 5% -40% 21%
10 4 5 8 5 4
EPS in Rs 211.28 20.11 29.52 4.13 1.92 1.78
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 16%
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 10%
TTM: -10%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -43%
Return on Equity
10 Years: %
5 Years: %
3 Years: 18%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 5 18 18 19 25 25
Reserves -13 1 1 13 51 67
33 18 14 30 41 40
20 19 21 18 10 9
Total Liabilities 45 56 54 79 127 140
16 25 25 24 23 22
CWIP 1 0 0 4 16 17
Investments 0 0 1 1 0 0
28 31 28 51 88 101
Total Assets 45 56 54 79 127 140

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3 6 10 -13 -34
-1 -1 -4 -5 -14
-1 -5 -6 18 48
Net Cash Flow 0 -0 0 -0 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 31 37 12 57 112
Inventory Days 78 75 99
Days Payable 74 54 22
Cash Conversion Cycle 31 37 17 78 189
Working Capital Days -10 11 18 49 126
ROCE % 25% 22% 18% 10%

Shareholding Pattern

Numbers in percentages

Sep 2024Mar 2025Sep 2025
69.90% 70.11% 70.15%
1.46% 0.01% 0.00%
4.11% 2.34% 1.96%
24.53% 27.54% 27.89%
No. of Shareholders 1,5201,3271,291

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings